News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Vista Energy posts high cashflow leverage in Vaca Muerta and 70% adjusted EBITDA margins, supporting bullish positioning.
  • Analyst recommends tactical mid-term long in VIST with entry $68, stop $63, and target $78 over about 45 trading days.
  • Bilibili schedules an Extraordinary General Meeting on Oct 28, 2026 to approve a $200M repurchase of 13.6M Class Z shares.
  • VEON and Bangladesh's Square Group received Bangladesh Bank approval for a digital bank license, enabling full-scale digital banking via Banglalink.
  • The license is part of VEON's $250M commitment to mobilize $1B in foreign investment for connectivity and financial services in Bangladesh.

Latest Articles

Celcuity Announces FDA Approval of REVTORPYK™ (gedatolisib) for the Treatment of HR+/HER2-, PIK3CA Wild-Type Locally Advanced or Metastatic Breast Cancer

Celcuity Announces FDA Approval of REVTORPYK™ (gedatolisib) for the Treatment of HR+/HER2-, PIK3CA Wild-Type Locally Advanced or Metastatic Breast Cancer

Celcuity Inc. announced FDA approval of REVTORPYK (gedatolisib), a kinase inhibitor targeting all class I PI3K isoforms and mTOR complexes, for the treatment of hormone receptor positive, HER2-negative, PIK3CA wild-type locally advanced or metastatic breast cancer. This approval is supported by positive Phase 3 VIKTORIA-1 trial results demonstratin…

QXO: Buy the Post-Deal Dip — The Machine Is Built, Now Buy Optionality

QXO: Buy the Post-Deal Dip — The Machine Is Built, Now Buy Optionality

QXO fell after completing a transformative $17B acquisition of TopBuild. The market sold the news on dilution and leverage, but the combined company should generate roughly $18B in revenue and $2B in adjusted EBITDA with $300M of synergies by 2030. At $14.48, QXO trades at a modest tangible book multiple with negative EPS but positive free cash flo…

Analog Devices Director Golz Executes Pre-Arranged Stock Sale

Analog Devices Director Golz Executes Pre-Arranged Stock Sale

Karen Golz, a director at Analog Devices Inc. (NASDAQ: ADI), executed a sale of 1,000 shares on July 13, 2026, totaling $389,830. The transaction was facilitated through a 10b5-1 trading plan established in March 2026 and occurred as the company’s stock has shown significant gains over the past year. Following the sale, Golz retains a direct holdin…

OpenAI Moves Into Home Audio: Screen-Free Speaker Sends Sonos Shares Lower

OpenAI Moves Into Home Audio: Screen-Free Speaker Sends Sonos Shares Lower

OpenAI is developing a mobile, screen-free smart speaker powered by ChatGPT that can proactively learn user habits and control smart-home devices. The report of the hardware push coincided with a sharp drop in Sonos shares, while Apple shares were largely unchanged. The move positions OpenAI against established hardware players as the company prepa…

Hepsiburada Announces Extraordinary General Assembly Meeting

Hepsiburada Announces Extraordinary General Assembly Meeting

Hepsiburada, a prominent Turkish e-commerce platform listed on NASDAQ (HEPS), announced an Extraordinary General Assembly Meeting scheduled for August 14, 2026, aiming to authorize a substantial share capital increase of TRY 9.32 billion. The share capital will increase from TRY 72.37 million to TRY 86.65 million through new share issuance, maintai…

SCHMID Group N.V. Provides Second Quarter 2026 Business Update and Full Year 2026 Order Guidance Update

SCHMID Group N.V. Provides Second Quarter 2026 Business Update and Full Year 2026 Order Guidance Update

SCHMID Group N.V., a global leader in electronics industry solutions, reported Q2 2026 order intake of €30.7 million and revenues of €27.7 million, with cumulative order intake reaching €81.6 million including a recent €37 million repeat order. The company raised its full-year 2026 order intake guidance to €125-150 million from approximately €114 m…

U.S. Markets End Mixed; S&P and Nasdaq Advance While Dow Holds Flat

U.S. Markets End Mixed; S&P and Nasdaq Advance While Dow Holds Flat

U.S. equities closed higher on Tuesday as gains in Technology, Basic Materials and Oil & Gas stocks drove the S&P 500 and Nasdaq to modest advances while the Dow finished essentially unchanged. Several large-cap and smaller-cap names posted outsized moves in both directions, and commodity and currency markets saw notable movement during the session…

Konstantin Lomashuk Offloads $20,846 in Forum Markets Equity

Konstantin Lomashuk Offloads $20,846 in Forum Markets Equity

Konstantin Lomashuk, a significant 10% stakeholder in Forum Markets Inc (NASDAQ: FRMM), executed a sale of his company's common stock on July 9, 2026. The transaction, totaling approximately $20,846, involved the disposition of 3,387 shares at a per-share price of $6.1548. These securities were held indirectly through Cyber Citadel, a Cayman Island…

Dime Commercial Bancshares to Release Earnings on July 23, 2026

Dime Commercial Bancshares to Release Earnings on July 23, 2026

Dime Commercial Bancshares, Inc., a New York State-chartered trust company with approximately $15 billion in assets, announced that it will release its earnings for the quarter ended June 30, 2026, before the U.S. markets open on July 23, 2026. The company will host a conference call featuring CEO Stuart Lubow to discuss the financial results, with…

Vivakor Announces 1-for-20 Reverse Stock Split

Vivakor Announces 1-for-20 Reverse Stock Split

Vivakor, Inc., a provider of integrated energy transportation and remediation services, announced a 1-for-20 reverse stock split effective July 17, 2026. The move aims to increase the per-share trading price and support the company's continued listing on the Nasdaq Capital Market. Shareholders approved a range of reverse splits at the 2026 annual m…

DBV Technologies to Report Second Quarter 2026 Financial Results and Business Update on July 16, 2026

DBV Technologies to Report Second Quarter 2026 Financial Results and Business Update on July 16, 2026

DBV Technologies, a late-stage biopharmaceutical company focused on food allergy treatments using its VIASKIN® patch technology, will report its second quarter 2026 financial results and provide a business update on July 16, 2026. The company will host a conference call and webcast for investors to discuss the results and ongoing clinical trial pro…